Completion of the Study. For purposes of this Agreement, Company and Institution shall consider the Study to be complete and concluded at all sites at such time as achievement of the primary endpoint is reached or as otherwise specified in the Protocol (“Study Conclusion”).
Appears in 2 contracts
Sources: Investigator Initiated Clinical Trial Agreement (Kazia Therapeutics LTD), Investigator Initiated Clinical Trial Agreement (Kazia Therapeutics LTD)